2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis
Crossref DOI link: https://doi.org/10.3389/fnins.2019.00394
Published Online: 2019-05-08
Update policy: https://doi.org/10.3389/crossmark-policy
Kennedy, Adam D.
Pappan, Kirk L.
Donti, Taraka
Delgado, Mauricio R.
Shinawi, Marwan
Pearson, Toni S.
Lalani, Seema R.
Craigen, William J.
Sutton, V. Reid
Evans, Anne M.
Sun, Qin
Emrick, Lisa T.
Elsea, Sarah H.
Version of Record valid from 2019-05-08
